Insmed
INSM
#902
Rank
S$34.58 B
Marketcap
S$158.36
Share price
1.14%
Change (1 day)
-14.67%
Change (1 year)

Earnings for Insmed (INSM)

Earnings in 2026 (TTM): -S$1.42 Billion

According to Insmed's latest financial reports the company's current earnings are S$0.81 Billion. In 2025 the company made an earning of -S$1.53 Billion a decrease over its 2024 earnings that were of -S$1.06 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insmed from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$1.42 Billion-7.38%
2025 -S$1.53 Billion43.91%
2024 -S$1.06 Billion23.71%
2023 -S$0.86 Billion45.77%
2022 -S$0.59 Billion15.83%
2021 -S$0.51 Billion50.19%
2020 -S$0.34 Billion16.4%
2019 -S$0.3 Billion-23.9%
2018 -S$0.39 Billion59.35%
2017 -S$0.24 Billion8.52%
2016 -S$0.23 Billion47.25%
2015 -S$0.15 Billion34.53%
2014 -S$0.12 Billion58.83%
2013 -S$70.1 Million35.14%
2012 -S$51.88 Million-31.92%
2011 -S$76.2 Million854.92%
2010 -S$7.98 Million-105.22%
2009 S$0.15 B-905.06%
2008 -S$18.98 Million-27.31%
2007 -S$26.11 Million-62.41%
2006 -S$69.45 Million98.19%
2005 -S$35.05 Million0.03%
2004 -S$35.03 Million159.07%
2003 -S$13.53 Million-69.31%
2002 -S$44.06 Million
2000 -S$39.73 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
S$20.16 B-1,532.77%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
S$13.70 B-1,073.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
S$6.46 B-559.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
S$31.25 M-102.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-S$29.69 Million-97.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
-S$30.04 Million-97.87%๐Ÿ‡บ๐Ÿ‡ธ USA